# Vitamin D and Health Outcomes: State-of-the-Art Review of Triangulated Evidence and Ongoing Controversies

**Authors:** Maria Dalamaga, Rodopi Emfietzoglou, Dimitra Petropoulou, Maria Kypraiou, Dimitris C. Kounatidis, Natalia G. Vallianou, Spyridon Karras, Faidon Magkos, Irene Karampela

PMC · DOI: 10.1007/s13668-026-00748-2 · 2026-03-18

## TL;DR

This review clarifies vitamin D's role in health by combining evidence from different study types, showing it's important for bones and some other conditions but not a universal solution.

## Contribution

The paper introduces a triangulated model reconciling conflicting evidence on vitamin D's health effects across study designs.

## Key findings

- Vitamin D strongly supports skeletal health and reduces fracture risk in deficient or older populations.
- Modest benefits are seen in cancer mortality, autoimmune disorders, and respiratory infections in those with low vitamin D.
- Cardiovascular and neuropsychiatric outcomes lack consistent evidence, suggesting limited or non-causal effects.

## Abstract

Vitamin D is a pleiotropic hormone with an established role in skeletal integrity and broader actions in immune regulation, inflammation, cellular proliferation, and energy homeostasis. Despite decades of research, its extra-skeletal effects remain controversial, largely due to discordant findings across observational studies, Mendelian randomization studies (MRS), and randomized controlled trials (RCTs). Unlike many prior reviews, this state-of-the-art review synthesizes triangulated evidence across these study designs to clarify outcome-specific causal relationships and ongoing controversies.

Triangulated evidence provides strong and consistent support for a causal role of vitamin D in skeletal health, particularly in the prevention and treatment of rickets and osteomalacia, and in fracture risk reduction among vitamin D–deficient and older populations. For selected extra-skeletal outcomes, modest and threshold-dependent benefits are observed, including reductions in cancer mortality, protection against autoimmune disorders, most convincingly multiple sclerosis, and decreased risk of acute respiratory infections, including COVID-19, primarily in individuals with low baseline 25(OH)D concentrations. In contrast, associations with cardiovascular disease, metabolic disorders, obesity, and most neuropsychiatric outcomes are not consistently supported by genetic or interventional evidence, suggesting limited or non-causal effects. Across outcomes, evidence indicates a non-linear relationship between vitamin D status and health, with increased risk concentrated at low 25-hydroxyvitamin D concentrations and limited benefit beyond sufficiency. All-cause mortality shows a modest, threshold-dependent association, with supplementation benefits largely confined to deficient or older populations. Key challenges include assay variability, non-linear dose–response relationships, and RCT designs that frequently enroll vitamin D–replete populations, resulting in substantial methodological heterogeneity and limiting causal inference.

Overall, the presented triangulated model may reconcile longstanding inconsistencies by reframing vitamin D as a context-dependent determinant of health. These findings argue against indiscriminate population-wide supplementation and support targeted strategies focused on the identification and correction of deficiency. Vitamin D should be regarded neither as a universal panacea nor as a trivial supplement, but as a context-dependent hormone whose clinical value lies in outcome-specific correction of deficiency.

Created in BioRender by Dimitra Petropoulou (January 20, 2026) BioRender.com/rd3udxs.

## Linked entities

- **Chemicals:** 25-hydroxyvitamin D (PubChem CID 5353325)
- **Diseases:** rickets (MONDO:0005520), osteomalacia (MONDO:0001068), cancer (MONDO:0004992), multiple sclerosis (MONDO:0005301), COVID-19 (MONDO:0100096), cardiovascular disease (MONDO:0004995), obesity (MONDO:0011122)

## Full-text entities

- **Genes:** CYP27A1 (cytochrome P450 family 27 subfamily A member 1) [NCBI Gene 1593] {aka CP27, CTX, CYP27}, ACE2 (angiotensin converting enzyme 2) [NCBI Gene 59272] {aka ACEH}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, NADSYN1 (NAD synthetase 1) [NCBI Gene 55191] {aka VCRL3}, IGHE (immunoglobulin heavy constant epsilon) [NCBI Gene 3497] {aka IgE}, DHCR7 (7-dehydrocholesterol reductase) [NCBI Gene 1717] {aka SLOS}, GC (GC vitamin D binding protein) [NCBI Gene 2638] {aka DBP, DBP-maf, DBP/GC, GRD3, Gc-MAF, GcMAF}, PTH (parathyroid hormone) [NCBI Gene 5741] {aka FIH1, PTH1}, CYP27B1 (cytochrome P450 family 27 subfamily B member 1) [NCBI Gene 1594] {aka CP2B, CYP1, CYP1alpha, CYP27B, P450c1, PDDR}, RXRA (retinoid X receptor alpha) [NCBI Gene 6256] {aka NR2B1, RXR-alpha, RXRalpha}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, CYP2R1 (cytochrome P450 family 2 subfamily R member 1) [NCBI Gene 120227], FGF23 (fibroblast growth factor 23) [NCBI Gene 8074] {aka ADHR, FGFN, HFTC2, HPDR2, HYPF, PHPTC}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, AGT (angiotensinogen) [NCBI Gene 183] {aka ANHU, SERPINA8, hFLT1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, CAMP (cathelicidin antimicrobial peptide) [NCBI Gene 820] {aka CAP-18, CAP18, CRAMP, FALL-39, FALL39, HSD26}, PDIA3 (protein disulfide isomerase family A member 3) [NCBI Gene 2923] {aka ER60, ERp57, ERp60, ERp61, GRP57, GRP58}, CYP24A1 (cytochrome P450 family 24 subfamily A member 1) [NCBI Gene 1591] {aka CP24, CYP24, HCAI, HCINF1, P450-CC24}, IL15 (interleukin 15) [NCBI Gene 3600] {aka IL-15}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1) [NCBI Gene 5564] {aka AMPK, HAMPKb}, VDR (vitamin D receptor) [NCBI Gene 7421] {aka NR1I1, PPP1R163}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}
- **Diseases:** schizophrenia (MESH:D012559), IPF (MESH:D054990), AF (MESH:D001281), inflammatory bowel disease (MESH:D015212), malabsorptive disorders (MESH:D008286), autoimmune thyroid disease (MESH:D013967), Myocardial Infarction (MESH:D009203), PAD (MESH:D058729), chronic kidney disease-mineral and bone disorder (MESH:D012080), fat loss (MESH:D004620), Preeclampsia (MESH:D011225), dyslipidemia (MESH:D050171), prediabetes (MESH:D011236), stroke (MESH:D020521), Hypovitaminosis D (MESH:D014808), ARIs (MESH:C535427), Autoimmune Disorders (MESH:D001327), SLE (MESH:D008180), insulin resistance (MESH:D007333), infection (MESH:D007239), dementia (MESH:D003704), angina (MESH:D000787), Metabolic Disorders (MESH:D008659), PSC (MESH:D015209), ARI (MESH:D012141), PBC (MESH:D008105), colorectal adenomas/serrated lesions (MESH:D000236), post-acute sequelae (MESH:D013313), diabetic complications (MESH:D048909), fungal (MESH:D009181), Overweight (MESH:D050177), Wheeze (MESH:D012135), metastasis (MESH:D009362), chronic illness (MESH:D002908), cardiac hypertrophy (MESH:D006332), neuropsychiatric (MESH:C000631768), Depression (MESH:D003866), NAFLD (MESH:D065626), Cancer (MESH:D009369), T2D (MESH:D003924), Obesity (MESH:D009765), fibrosis (MESH:D005355), CV death (MESH:D003643), pneumonia (MESH:D011014), dental caries (MESH:D003731), GH (MESH:D006432), lung cancer (MESH:D008175), MS (MESH:D009103), carcinogenesis (MESH:D063646), Falls (MESH:C537863), hip fracture (MESH:D006620), Asthma (MESH:D001249), T1D (MESH:D003922), acute (MESH:D000208), vertebral fracture (MESH:C535781), fibromyalgia (MESH:D005356), HT (MESH:D006973), Kidney Stone Disease (MESH:D007669), long COVID (MESH:D000094024), Autoimmune Liver Disease (MESH:D008107)
- **Chemicals:** vitamin K2 (MESH:D024482), CHO (MESH:C034482), TG (MESH:D013866), Vitamin D3 (MESH:D002762), magnesium (MESH:D008274), CA (MESH:D002118), phosphate (MESH:D010710), nitric oxide (MESH:D009569), cholesterol (MESH:D002784), 1,25(OH)2D (MESH:C097949), LDL-C (-), B9 (MESH:C014499), oxygen (MESH:D010100), 7-DHC (MESH:C016705), glycemia (MESH:D001786), Vitamin K1 (MESH:D010837), 25-hydroxyvitamin D3 (MESH:D002112), 25-hydroxyvitamin D (MESH:C104450), vitamin B12 (MESH:D014805), gadolinium (MESH:D005682), Vitamin C (MESH:D001205), steroid (MESH:D013256), 1,25(OH)2D3 (MESH:D002117), Vit-D (MESH:D014807), ergocalciferol (MESH:D004872), Vitamin B6 (MESH:D025101), P (MESH:D010758), triglycerides (MESH:D014280), D (MESH:D003903), glucose (MESH:D005947), lipid (MESH:D008055), Hcy (MESH:D006710)
- **Species:** Rodentia (rodent, order) [taxon 9989], Mus musculus (house mouse, species) [taxon 10090], gut metagenome (species) [taxon 749906], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** rs10741657, D in 26916, rs7041, rs117913124, rs17216707, rs8018720, rs10745742, rs3755967, rs12785878
- **Cell lines:** AMSTAR-2 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_A628)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12999768/full.md

---
Source: https://tomesphere.com/paper/PMC12999768